The notices it replaced
Its page names no earlier notice: it is new, or it does not say.
Replaced by RFA-CA-20-002.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 5 new
- Median first-year cost
- $2,908,438
- $14,024,953 in all
- Institutions
- 4
- 4 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP2
- ECOG-ACRIN MEDICAL RESEARCH FOUNDATION1
- NRG ONCOLOGY FOUNDATION, INC.1
- WASHINGTON UNIVERSITY1
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-S (J2))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE1U24CA196171-01 | Caligiuri, Michael ACicek, MineFrankel, WendyRichards, William GWatson, Mark A. | WASHINGTON UNIVERSITY, MO | First-year cost $3,327,369 | Study section ZCA1 |
| FY2015 | SWOG Biospecimen Bank1U24CA196175-01 | Gastier-Foster, Julie MRae, James MichaelRamirez Milan, Nilsa Del Carmen | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | First-year cost $3,211,645 | Study section ZCA1 |
| FY2015 | COG Biospecimen Bank1U24CA196173-01 | Gastier-Foster, Julie MRamirez Milan, Nilsa Del Carmen | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | First-year cost $2,908,438 | Study section ZCA1 |
| FY2015 | NRG Oncology Biospecimen Bank1U24CA196067-01 | Jordan, Richard CPaik, SoonmyungRamirez Milan, Nilsa Del Carmen | NRG ONCOLOGY FOUNDATION, INC., PA | First-year cost $2,292,426 | Study section ZCA1 |
| FY2015 | ECOG-ACRIN Biorepositories to Support NCTN1U24CA196172-01 | Hamilton, Stanley R.Wistuba, Ignacio I. | ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, PA | First-year cost $2,285,075 | Study section ZCA1 |
Patents from its funded projects
1 patent names 1 of the 5 funded projects.
- US 11,028,448 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF IDENTIFYING RISK OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PATHWAY INHIBITOR-INDUCED HYPERTENSIONGranted June 8, 2021 to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL and Duke UniversityU24CA196171 · WASHINGTON UNIVERSITY, MO
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.